Orchid Pharma slipped 6.53% to Rs 1,025.35 after the pharma company’s consolidated net profit tumbled 49.19% to Rs 33.50 crore in Q4 FY24 as compared with Rs 65.93 crore in Q4 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
